TOP STORIES
FDA regulated digital health solutions could save the US healthcare system $100 billion by 2018, according to a new report from Accenture. The solutions cost savings was $6 billion in 2014 and are expected to rise to $50 billion in the next four years.Where will the cost savings cost from? Medication adherence, behavior modifications and fewer emergency room visits, the report said.
Accenture also projects that FDA approvals of digital health tools will triple by the end of 2018 to 100 compared with 33 last year.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Negotiations on the TranPacific trade agreement have hit a snag over a push by pharmaceutical companies to lock in 12 years of monopoly pricing power for drugs to treat conditions such as cancer. Critics and international relief organizations are concerned that this would lock in higher costs and mean fewer people in developing countries could afford the life-saving medication. Even though the majority of the Trans-Pacific Partnership oppose the measure, Republicans and some Democrats support it.
Evolent Health’s (NYSE: EVH) initial public offering priced at $17, higher than the $14-$16 that was projected. It starts trading today.
LIFE SCIENCES
US pharmaceutical company AbbVie sent a Citizen Petition to the FDA arguing that biosimilar products should not be labeled like generic drugs.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
A drug meant to boost women’s sexual desire, flibanserin, has been approved by U.S. Food and Drug Administration panel, after being rejected by the agency twice in recent years.
Here’s a look at the Destination Medical Center — a 20-year project with $6.5 billion in funding to transform Rochester, Minnesota, the home of the Mayo Clinic, into a global biotech and medical hub.
Calhoun Vision raised $69 million in funding for a ight-adjustable intra-ocular lens.
PAYERS-PROVIDERS
A behind-the-scenes look at how hospitals are tracking how patients rate them and the people tasked with presenting that information to them.
Two big hospital mergers in New Jersey could spell potential disaster for the New York health system.
A baby who had heart surgery at St. Mary’s Medical Center in Florida died Tuesday, at least the ninth infant to pass away after such a procedure since the program opened at the end of 2011.
TECH
Telemedicine provider Carena raised $13.3 million from Cambia Health Solutions, McKesson Ventures, Catholic Health Initiatives and Martin Ventures to fund development of Carena’s Virtual Clinic solutions for hospital systems.
After acquiring DoctorBase in March, Kareo finally completed the product integration with the practice marketing and patient engagement solution.
POLITICS
House conservatives revealed the newest version of their Obamacare replacement plan, intentionally leaving out King v. Burwell.
A LITTLE EXTRA
A rat forelimb growth becomes the world’s first biolimb.
The Morning Read provides a 24-hour wrap up of everything else healthcare’s innovators need to know about the business of medicine (and beyond). The author of The Read published it but all full-time MedCity News journalists contribute to its content.
Photo: Flickr user CarbonNYC
